Search research articles
Contact Us
Filters
Showing results (31-40 of 67) with videos related to
Page
of 7
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 30, 2019
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)
Fady M Mikhail, Jaclyn A Biegel, Linda D Cooley, et al.
Pediatric Blood & Cancer
|
September 17, 2013
Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group
Donna L Johnston, Todd A Alonzo, Robert B Gerbing, et al.
Transfusion
|
June 20, 2008
Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues
Jeffrey McCullough, Jeffrey Kahn, John Adamson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 9, 2011
Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization
James T Mascarello, Betsy Hirsch, Hutton M Kearney, et al.
American Journal of Hematology
|
July 10, 2007
Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis
Catherine M Flynn, Betsy Hirsch, Todd Defor, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 28, 2019
ADDENDUM: Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in situ hybridization
James T Mascarello, Betsy Hirsch, Hutton M Kearney, et al.
Molecular Syndromology
|
June 22, 2018
Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions
Hannah C D Esdal, Muhammad B Ghbeis, Daniel A Saltzman, et al.
Blood
|
March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
Jessica A Pollard, Todd A Alonzo, Michael Loken, et al.
Cancer Genetics
|
February 14, 2015
Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study
Linda B Baughn, Jaclyn A Biegel, Sarah T South, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 67) with videos related to
Sort By:
Page
of 7
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 30, 2019
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)
Fady M Mikhail, Jaclyn A Biegel, Linda D Cooley, et al.
Pediatric Blood & Cancer
|
September 17, 2013
Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group
Donna L Johnston, Todd A Alonzo, Robert B Gerbing, et al.
Transfusion
|
June 20, 2008
Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues
Jeffrey McCullough, Jeffrey Kahn, John Adamson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 9, 2011
Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization
James T Mascarello, Betsy Hirsch, Hutton M Kearney, et al.
American Journal of Hematology
|
July 10, 2007
Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis
Catherine M Flynn, Betsy Hirsch, Todd Defor, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 28, 2019
ADDENDUM: Section E9 of the American College of Medical Genetics Technical Standards and Guidelines: Fluorescence in situ hybridization
James T Mascarello, Betsy Hirsch, Hutton M Kearney, et al.
Molecular Syndromology
|
June 22, 2018
Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions
Hannah C D Esdal, Muhammad B Ghbeis, Daniel A Saltzman, et al.
Blood
|
March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
Jessica A Pollard, Todd A Alonzo, Michael Loken, et al.
Cancer Genetics
|
February 14, 2015
Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study
Linda B Baughn, Jaclyn A Biegel, Sarah T South, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Page
of 7